AI is not the ‘what’. It is simply the ‘how’.
Sponsors are tired of hearing what powers the work. They want to know what the work actually delivers.
What keeps people of color out of clinical trials
Most campaigns treat underrepresentation as the problem. The research says distrust is the cause.
Why Applying to a Depression Study Takes Courage
The symptoms that define depression are the same ones that make seeking help hard. Recruitment that ignores that builds its own enrollment gap.
Clinical trial retention starts before randomization
A 2024 analysis of nearly 800 trials found that the harder a consent form was to read, the more patients dropped out. The decision to stay is often made long before randomization. Here is what that means for how studies recruit.
The gap between Alzheimer’s research and the people who need it most
For Dan, CEO and founder of 1nHealth, Alzheimer’s disease is not a therapeutic area on a strategy deck. He lost his grandmother to it. That loss is part of why he built this company, and part of why closing the distance between Alzheimer’s research and the communities it was designed to serve sits at the center of what 1nHealth does.